Personalizing cancer
care management
Custom-built testing for each cancer patient, to detect molecular residual disease (MRD) and help guide treatment decisions.
Assessing the health
of transplant patients
The most precise cell-free DNA (cfDNA) testing in organ health—developed from our trusted legacy.
Informing women's health decisions
Women’s health testing for every phase of life—from planning a family and checking baby’s health to assessing risk for hereditary cancer.
OUR TECHNOLOGY
Natera's core technology and finely tuned workflows cut through the noise to deliver superior clinical and analytical performance.
